
D-Lactic Acid LA Colorimetric Assay Kit - E-BC-K002-M
etection principle
Using NAD+ as H+ receptor, D-lactate dehydrogenase (LDH) catalyzes the reaction of D-lactic acid and NAD+ to generate pyruvic acid and NADH respectively. NBT is reduced to a kind of purple compound during the reaction. Measure the OD value at 530 nm, and the concentration of D-lactic acid can be calculated.#N/A
Performance characteristics
Synonyms | D-LA |
Sample type | Serum, plasma, animal tissue, saliva sample |
Sensitivity | 0.06 mmol/L |
Detection range | 0.06-8.0 mmol/L |
Detection method | Colorimetric method |
Assay type | Quantitative |
Assay time | 20 min |
Precision | Average inter-assay CV: 7.700%Average intra-assay CV: 3.800% |
Other instruments required | Micropipettor, Vortex mixer, Incubator, Centrifuge |
Other reagents required | PBS (0.01 M, pH 7.4) |
Storage | 2-8℃ |
Valid period | 12 months |
Images
Plasma D-LA level was significantly increased in VDN group, and reversed in SP treated group. (****P<0.0001)
Jianlong Yan et al investigates the beneficial effect of the short-chain fatty acid in intestinal microbiota remodeling. Plasma D-Lactate of rat was determined using D-lactate colorimetric assay kit (E-BC-K002-M).
Dilution of sample
It is recommended to take 2~3 samples with expected large difference to do pre-experiment before formal experiment and dilute the sample according to the result of the pre-experiment and the detection range (0.06-8.0 mmol/L).
The recommended dilution factor for different samples is as follows (for reference only):
Sample type |
Dilution factor |
Human plasma |
1 |
Human serum |
1 |
Rat serum |
1 |
Rat plasma |
1 |
Mouse serum |
1 |
Rabbit serum |
1 |
10% Rat kidney tissue homogenate |
2-3 |
10% Mouse brain tissue homogenate |
1 |
Note: The diluent is normal saline (0.9% NaCl) or PBS (0.01 M, pH 7.4).
-
Microbiome (2022) IF: 16.837
Beneficial effect of the short-chain fatty acid propionate on vascular calcification through intestinal microbiota remodellingSample: plasma -
International Journal of Nanomedicine (2023) IF: 7.033
Nano Parthenolide Improves Intestinal Barrier Function of Sepsis by Inhibiting Apoptosis and ROS via 5-HTR2ADOI: 10.2147/IJN.S394544
Sample: blood